These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 21598296)
21. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels. Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain. Lan Y; Chen Y; Cao X; Zhang J; Wang J; Xu X; Qiu Y; Zhang T; Liu X; Liu BF; Zhang G J Med Chem; 2014 Dec; 57(24):10404-23. PubMed ID: 25420090 [TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes. Quaglia W; Pigini M; Piergentili A; Giannella M; Marucci G; Poggesi E; Leonardi A; Melchiorre C J Med Chem; 1999 Jul; 42(15):2961-8. PubMed ID: 10425105 [TBL] [Abstract][Full Text] [Related]
24. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging. Yao BB; Hsieh G; Daza AV; Fan Y; Grayson GK; Garrison TR; El Kouhen O; Hooker BA; Pai M; Wensink EJ; Salyers AK; Chandran P; Zhu CZ; Zhong C; Ryther K; Gallagher ME; Chin CL; Tovcimak AE; Hradil VP; Fox GB; Dart MJ; Honore P; Meyer MD J Pharmacol Exp Ther; 2009 Jan; 328(1):141-51. PubMed ID: 18931146 [TBL] [Abstract][Full Text] [Related]
25. N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor. Lee J; Lee J; Kang M; Shin M; Kim JM; Kang SU; Lim JO; Choi HK; Suh YG; Park HG; Oh U; Kim HD; Park YH; Ha HJ; Kim YH; Toth A; Wang Y; Tran R; Pearce LV; Lundberg DJ; Blumberg PM J Med Chem; 2003 Jul; 46(14):3116-26. PubMed ID: 12825950 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic. Lan Y; Chen Y; Xu X; Qiu Y; Liu S; Liu X; Liu BF; Zhang G Eur J Med Chem; 2014 May; 79():216-30. PubMed ID: 24735647 [TBL] [Abstract][Full Text] [Related]
27. Antiallodynic and antihyperalgesic effects of selective competitive GLUK5 (GluR5) ionotropic glutamate receptor antagonists in the capsaicin and carrageenan models in rats. Jones CK; Alt A; Ogden AM; Bleakman D; Simmons RM; Iyengar S; Dominguez E; Ornstein PL; Shannon HE J Pharmacol Exp Ther; 2006 Oct; 319(1):396-404. PubMed ID: 16837561 [TBL] [Abstract][Full Text] [Related]
28. Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety. Bergkemper M; Kronenberg E; Thum S; Börgel F; Daniliuc C; Schepmann D; Nieto FR; Brust P; Reinoso RF; Alvarez I; Wünsch B J Med Chem; 2018 Nov; 61(21):9666-9690. PubMed ID: 30350997 [TBL] [Abstract][Full Text] [Related]